- Depressed mood
- Depression
Katherine Wilson Scangos, MD, PhD
About me
- Associate Professor of Neurosurgery at the Hospital of the University of Pennsylvania
- Associate Professor of Psychiatry at the Hospital of the University of Pennsylvania
My education and training
- Medical School: Johns Hopkins University School of Medicine
- Residency: UC Davis Medical Center
- Fellowship: University of California San Francisco
Spoken languages
Insurance accepted
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
- Pennsylvania Hospital: Has privileges to treat patients in the hospital.
Qualifications and experience
- Psychiatry, 2017
- American Board for Psychiatry and Neurology, National
- Attune Neurosciences, National
- Bioengineering Graduate Group, Local
- Brain Stimulation Subspecialty Summit, National
- Glioma Connectome Project, National
- Johnson & Johnson, National
- National Institute of Health: 01 ZRG1 NPE-P (82) S. Special Emphasis Panel. (Nov 2026), National
- National Institute of Health: ZRG1 CN-U Special Emphasis Panel. SRO Chi-Tso. Chiu, National
Treatments and conditions
Research
Publications
Farooqui J, Toennies J, Mintch LM, Nelson J, Yudkoff B, Cristancho M, Scangos K, Halpern CH, Robinson JT, Wexler A. What matters in next-generation implanted neurotechnology design? Perspectives from individuals with treatment-refractory depression , J Neural Eng: 2026
Lauro PM, Palmer CF, Nambiar MM, Muller U, Qiu L, Halpern CH, Scangos KW. Circuit-based neuromodulation for obsessive-compulsive disorder: a review of prior and emerging methods , Front Psychiatry, 17: 2026,1828620
Seilheimer RL, Qiu L, Rocchio G, Nho YH, Campos G, Horn A, Rolle CE, Buch VP, Ganguly TM, Cristancho M, Oathes DJ, Brown L, Pesaran B, Krystal AD, Chang EF, Lee MA, Miller KJ, Barbosa DAN, Williams NR, Halpern CH, Scangos KW. Stereo-encephalography-guided multi-lead deep brain stimulation for treatment-refractory obsessive compulsive disorder - Study design and individualized surgical targeting approach , J Affect Disord, 402: 2026,121349
Fleeting CR, Moraud EM, Uğurbil K, Wang DD, Neumann WJ, Kühn AA, Voon V, Pikov V, Welter ML, Fox MD, Rolston JD, Malekmohammadi M, Pathak YJ, Himes LM, Greene D, Holt-Becker AS, Lázaro-Muñoz G, Charney AW, Merner AR, Figee M, Scangos KW, Denison T, Leyde K, Gunduz A, Bronte-Stewart HM, Beck JC, Vanegas-Arroyave N, Luciano MS, Brüggemann N, Foote KD, Okun MS, Wong JK. Proceedings of the 13th annual deep brain stimulation think tank: the evolving landscape , Front Hum Neurosci, 20: 2026,1770451
Nho YH, Qiu L, Seilheimer RL, Campos G, Chang A, Wang Z, Magnotti JF, Beauchamp MS, Barbosa DAN, Horn A, Williams NR, Brown LA, Ganguly TM, Cristancho M, Pesaran B, Oathes DJ, Miller KJ, Scangos KW, Halpern CH. Human orbitofrontal neural activity is linked to obsessive-compulsive behavioral dynamics , Cell, 189: 2026,739-747
Qiu L, Nho YH, Seilheimer RL, Kim MJ, Tufanoglu A, Williams NR, Wexler A, Oslin DW, Millet B, Scangos KW, Pesaran B, Evins AE, Richardson RM, Childress AR, Halpern CH. Electrographic cue-reactivity co-localizes with accumbens deep brain stimulation in a case of opioid use disorder , Nat Commun, 17: 2026,1708
Howard SD, Qiu L, Hager N, Childress AR, Halpern CH, Scangos KW. Emerging neuromodulation treatments for opioid and stimulant use disorders , Front Hum Neurosci., 19: 2025
Seilheimer RL, Qiu L, Rocchio G, Nho YH, Campos G, Horn A, Rolle CE, Buch VP, Ganguly TM, Cristancho M, Oathes DJ, Brown L, Pesaran B, Krystal AD, Chang EF, Lee ME, Miller KJ, Williams NR, Barbosa DAN, Scangos KW, Halpern CH. Stereo-encephalography-guided multi-lead deep brain stimulation for treatment-refractory obsessive compulsive disorder - study design and individualized surgical targeting approach , medRxiv: 2025
Siddiqi SH, Chen L, Trapp NT, Bukhari-Parlakturk N, Taylor JJ, Boes AD, Brown JC, Barbour T, Camprodon JA, Fox MD, Kopell BH, MacMillan C, Fasano A, Fisher RS, Nahas Z, Revuelta GJ, Riva-Posse P, Rolston JD, Scangos K, Shafi MM, Smith AH, Wong J, Halpern CH, Mayberg HS, Williams NR. Towards accredited clinical training in brain stimulation: Proceedings from the brain stimulation subspecialty summits , Brain Stimulation, 18(2): 2025,298-305
Liming Qiu, Young-Hoon Nho, Robert Seilheimer, Min Jae Kim, Altona Tufanoglu, Nolan R. Williams, Anna Wexler, David W. Oslin, Bruno Millet, Katherine W. Scangos, Bijan Pesaran, A. Eden Evins, R. Mark Richardson, Anna-Rose Childress, Casey H. Halpern Localizing electrophysiologic cue-reactivity within the nucleus accumbens guides deep brain stimulation for opioid use disorder , BioRXiv: 2025